M. Yoshida et al. / Tetrahedron Letters 46 (2005) 6705–6708
6707
References and notes
10 mol %
Pd(PPh3)4
Ph
1. For selected reviews, see: (a) Marshall, J. A. Chem. Rev.
2000, 100, 3163; (b) Zimmer, R.; Dinesh, C. U.; Nanda-
nan, E.; Khan, F. A. Chem. Rev. 2000, 100, 3067; (c) Ma,
S. Acc. Chem. Res. 2003, 36, 701; (d) Hashmi, A. S. K.
Angew. Chem., Int. Ed. 2000, 39, 3590; (e) Hoffmann-
Ro¨der, A.; Krause, N. Angew. Chem., Int. Ed. 2002, 41,
2933; (f) Krause, N.; Hoffmann-Ro¨der, A.; Canisius, J.
Synthesis 2002, 1759; (g) Hoffmann-Ro¨der, A.; Krause, N.
Angew. Chem., Int. Ed. 2004, 43, 1196.
OH
O
B(OH)2
·
+
Ph
solvent, 80 C
˚
2 h
2a
(1R,2R)-1a
92% ee
(1R,2R)-3aa
92%, 92% ee
Scheme 2.
2. (a) Krause, N.; Hoffmann-Ro¨der, A. Allenic Natural
Products and Pharmaceuticals. In Modern Allenic Chem-
istry; Krause, N., Hashmi, A. S. K., Eds.; Wiley-VCH:
Weinheim, 2004, p 997; (b) Landor, S. R. Naturally
Occurring Allenes. In The Chemistry of the Allenes;
Landor, S. R., Ed.; Academic Press: London, 1982,
p 679; (c) Claesson, A. Biologically Active Allenes. In
The Chemistry of the Allenes; Landor, S. R., Ed.;
Academic Press: London, 1982, p 709; (d) Robinson, C.
H.; Covey, D. F. Biological Formation and Reactions. In
The Chemistry of Ketenes, Allenes and Related Compounds;
Patai, S., Ed.; Wiley: Chichester, 1980, p 451.
Ar
OH
Ph
O
·
Ph
3
1
Pd(0)
Ar
Pd
Pd
OH
O
·
·
Ph
Ph
3. Alexakis, A.; Marek, I.; Mangeney, P.; Normant, J. F.
Tetrahedron 1991, 47, 1677.
5
8
4. (a) Vermeer, P.; Meijer, J.; De Graaf, C.; Schreures, H.
Rec. Trav. Chim. Pays-Bas 1974, 93, 46; (b) Oehlschlager,
A. C.; Czyzewska, E. Tetrahedron Lett. 1983, 24, 5587; (c)
Johnson, C. R.; Dhanoa, D. S. J. Org. Chem. 1987, 52,
1885; (d) Marshall, J. A.; Pinney, K. G. J. Org. Chem.
1993, 58, 1885; (e) Bertozzi, F.; Crotti, P.; Macchia, F.;
Pineschi, M.; Arnold, A.; Feringa, B. L. Tetrahedron Lett.
1999, 40, 4893.
B(OH)4
H2O
OH
Ph
Pd
OH
·
ArB(OH)3
7
6
´
5. Furstner, A.; Mendez, M. Angew. Chem., Int. Ed. 2003,
¨
Scheme 3.
42, 5355.
6. (a) Mori, K. Tetrahedron 1974, 30, 1065; (b) Ito, M.;
Hirata, Y.; Tsukida, K.; Tanaka, N.; Hamada, K.; Hino,
R.; Fujiwara, T. Chem. Pharm. Bull. 1988, 36, 3328; (c)
Braumeler, A.; Brade, W.; Haag, A.; Eugster, C. H. Helv.
Chim. Acta 1990, 73, 700.
Plausible mechanism for the formation of aryl-substi-
tuted 2,3-allenols 3 is shown in Scheme 3. In the first
step, regio- and stereoselective anti-SN20 attack of palla-
dium catalyst14 on the propargylic oxirane 1 takes place
to yield the twitter ionic allenylpalladium species 5,
which was further hydrated in the presence of H2O to
form the allenylpalladium hydroxide 6.15 Transmetalla-
tion of 6 with arylborate 7,16 derived from arylboronic
acid 2 and H2O, and then reductive elimination of
palladium from the resulting intermediate 8 diastereo-
selectively produces anti-coupled 4-aryl-2,3-allenol 3.
7. Kleijn, H.; Meijer, J.; Overbeek, G. C.; Vermeer, P. Rec.
Trav. Chim. Pays-Bas 1982, 101, 97.
´
´
8. Kjellgren, J.; Sunden, H.; Szabo, K. J. J. Am. Chem. Soc.
2005, 127, 1787.
9. Knight, J. G.; Ainge, S. W.; Baxter, C. A.; Eastman, T. P.;
Harwood, S. J. J. Chem. Soc., Perkin Trans. 1 2000, 3788.
10. Substrate 1 was easily prepared by the epoxidation of the
corresponding known eneyne with m-CPBA in moderate
to good yields.
11. Typical procedure: to a stirred solution of propargylic
oxirane 1a (45.0 mg, 0.227 mmol) in 1,4-dioxane (2.0 ml)
and H2O (1.0 ml) were added 2-methylphenylboronic acid
(2a) (92.8 mg, 0.682 mmol) and Pd(PPh3)4 (26.3 mg,
22.7 lmol) at rt, and the stirring was continued for 1.5 h
at 80 °C. After filtration of the reaction mixture using
small amount of silica gel, the mass was extracted with
AcOEt. The combined filtrates were washed with 10%
aqueous NaOH and brine, and the residue upon workup
was chromatographed on silica gel with hexane–AcOEt
(90:10, v/v) as eluent to give the 4-aryl-2,3-allenol 3aa
(60.3 mg, 92%) as colourless crystals; mp 98–99 °C; IR
In conclusion, the effort described above has led to the
discovery of a palladium-catalyzed coupling reaction
occurring between propargylic oxiranes and arylboronic
acids. The process can be carried out in aqueous condi-
tions to yield anti-substituted 4-aryl-2,3-allenols in a
highly diastereoselective manner. Furthermore, the
chiral-substituted allene has been synthesized from the
chiral propargylic oxirane without loss of the chirality.
Continuing studies probing the scope and synthetic
applications of this reaction are now in progress.
1
(neat) 3342, 2933, 1948, 1595 cmꢀ1; H NMR (400 MHz,
CDCl3) d 7.30–7.15 (9H, m), 4.12–4.05 (1H, m), 2.62–2.55
Acknowledgement
(1H, m), 2.20 (3H, s), 2.24–2.05 (2H, m), 1.95–1.85 (1H,
m), 1.92 (1H, s), 1.85–1.75 (1H, m), 1.62–1.38 (3H, m); 13
C
This study was supported in part by a Grant-in-Aid for
the Encouragement for Young Scientists (B) from the
Japan Society for the Promotion of Science (JSPS) (for
M.Y.).
NMR (100 MHz, CDCl3) d 195.4, 137.3, 136.5, 136.5,
130.3, 130.2, 128.3, 127.5, 126.7, 126.5, 125.8, 111.5, 110.9,
69.6, 36.6, 30.1, 27.1, 23.9, 20.2; MS m/z 290 (M+); HRMS
m/z calcd for C21H22O: 290.1671 (M+). Found: 290.1688.